| Residency: | Columbia-Presbyterian Hospital of Physicians & Surgeons;
New York City, NY - 2002 |
| Internship: | University of Utah; Salt Lake City,UT - 1999 |
| MedSchool: | University of Pennsylvania; Philadelphia, PA - 1998 |
| UnderGrad: | University of Pennsylvania; Philadelphia, PA - 1998 |
| Publications: | Uyttendaele H, Koss T, Bagheri B, Schneiderman P, Silfen ME, Gallagher MP, Garzon M, Engler D. Generalized acanthosis nigricans in an otherwise healthy young child.
Pediatr Dermatol. 2003 May-Jun;20(3):254-6.
Koss T, Bagheri B, Zeana C, Romangoli MF, Grossman ME. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.J Am Acad Dermatol. 2002 Jun;46(6):945-7.
Rubin AI, Bagheri B, Scher RK. Six novel antimycotics. Am J Clin Dermatol. 2002;3(2):71-81. Review
Moosavi M, Bagheri B, Scher RK. Systemic Antifungal Therapy. Dermat Clin 2001 Jan 19(1):35-52
Hall RP, Owen S, Smith A, Keough M, Bagheri B, Church P, Streilein R. TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy. Exp Dermatol. 2000 Aug;9(4):275-82.
Smith AD, Bagheri B, Streilein RD, Hall RP. Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci. 1999 Oct;44(10):2124-32.
Hecker MS, Weinberg JM, Bagheri B, Tangoren IA, Rudikoff D,, Bottone E, Bilodeau- Mc Carthy E, Rudolph RI, Phelps RG. Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol. 1997 Aug; 37(2 pt 1):270-1 |
|